Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.

Berger CT, Kim AY. IL28B polymorphisms as a pretreatment predictor of response to HCV treatment. Infect Dis Clin North Am. 2012 Dec; 26(4):863-77.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.